Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Bioactive compounds in mushrooms may fight neurodegeneration in later life

New research suggests that mild cognitive impairment could be prevented in people over the age of 60 by simply eating mushrooms more than twice a week.

15 Mar 2019

Patient monitoring technology helps mental health trust to reduce falls and save time

Coventry and Warwickshire Partnership NHS Trust saw falls at night drop by a third on two wards that introduced the Oxehealth Digital Care Assistant technology, a clinical study has shown.

15 Mar 2019

Study: More vitamin D may boost memory but too much could lead to slower reaction time

How much vitamin D can boost memory, learning and decision-making in older adults, and how much is too much?

15 Mar 2019

New treatment approach could minimize brain damage caused by stroke

In a study published today in the Journal of Experimental Medicine, researchers successfully used a new approach that significantly minimized brain damage caused by stroke in mouse models.

14 Mar 2019

Oral bacteria in pancreas associated with tumor severity

The presence of oral bacteria in so-called cystic pancreatic tumours is associated with the severity of the tumour, a study by researchers at Karolinska Institutet in Sweden published in the journal Gut reports. It is hoped that the results can help to improve diagnosis and treatment of pancreatic cancer.

14 Mar 2019

New study aims to detect Parkinson's at much earlier stage

A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson's, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.

13 Mar 2019

“Fail Fast, But More Confidently”: Developing Organoids for Drug Development and Discovery

Richard Eglen discusses the use of organoids in drug discovery, including the screening of candidate compounds for efficacy, toxicity, and pharmacokinetics.

From Corning Life Sciences 13 Mar 2019

Study unravels how cancer medication works in brains of Parkinson's patients

Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson's disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms of Parkinson's, such as motor dysfunction, are a result of a dopamine loss.

13 Mar 2019

New evidence found for role of human hippocampus in future planning

A team of scientists reports finding the first evidence that the human hippocampus is necessary for future planning. Its findings, published in the journal Neuron, link its long-established role in memory with our ability to use our knowledge to map out the future effects of our actions.

13 Mar 2019

Study uncovers dramatic differences in the brains of Hispanics with dementia

A major new study from the UC Davis Alzheimer's Center has uncovered dramatic differences in the brains of Hispanics with a dementia diagnosis compared with those of non-Hispanic whites and of African Americans.

12 Mar 2019

Physical activity may reduce mortality risk among cognitively frail individuals

Cognitive frailty is a heterogeneous clinical manifestation characterized by the simultaneous presence of both physical frailty and cognitive impairment, in the absence of dementia, and it seems to entail a greater death risk than physical frailty or cognitive impairment separately.

12 Mar 2019

Alzheimer’s and brain health could soon be detected using an eye exam

Soon, an eye examination may be all that is needed to confirm a diagnosis of Alzheimer's disease, according to researchers at Duke's Health.

12 Mar 2019

UVA researchers discover potential contributor to age-related hearing loss

Researchers at the University of Virginia School of Medicine have discovered a new potential contributor to age-related hearing loss, a finding that could eventually help doctors identify people at risk.

12 Mar 2019

Mushroom consumption may reduce odds of having mild cognitive impairment

A team from the Department of Psychological Medicine and Department of Biochemistry at the Yong Loo Lin School of Medicine at the National University of Singapore has found that seniors who consume more than two standard portions of mushrooms weekly may have 50 per cent reduced odds of having mild cognitive impairment.

12 Mar 2019

New non-invasive imaging device can quickly detect signs of Alzheimer's disease

Researchers from the Duke Eye Center have shown that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds.

11 Mar 2019

Study finds higher risk of head injuries in persons with Alzheimer’s disease

Persons with Alzheimer’s disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer’s disease, a recent study from University of Eastern Finland shows.

11 Mar 2019

Smoking, high blood pressure, obesity and diabetes associated with less healthy brains

Factors that influence the health of our blood vessels, such as smoking, high blood and pulse pressures, obesity and diabetes, are linked to less healthy brains, according to research published in the European Heart Journal today (Monday).

11 Mar 2019

Researchers explore how the brain changes over the course of Alzheimer's disease

What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.

9 Mar 2019

Healthy diets may protect against dementia

The best way to keep your mind sharp as you age is to eat a healthy diet, according to recent research.

8 Mar 2019

Research team identifies potential target protein aggregates for treating Alzheimer's disease

The aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neurodegenerative diseases. These aggregates propagate from one neuronal cell to another, attaching themselves to the cells.

8 Mar 2019